Back to Journals » Vascular Health and Risk Management » Volume 7 » default
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1518)
- Volume 20, 2024 (22)
- Volume 19, 2023 (86)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 7, 2011
Benefits of once-daily therapies in the treatment of hypertension
Flack JM, Nasser SA
Vascular Health and Risk Management 2011, 7:777-787
Published Date: 21 December 2011
The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive
Falskov B, Hermann TS, Rask-Madsen C, Major-Pedersen A, Christiansen B, Raunsø J, Køber L, Torp-Pedersen C, Dominguez H
Vascular Health and Risk Management 2011, 7:771-776
Published Date: 19 December 2011
Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon
Mengden T, Hübner R, Bramlage P
Vascular Health and Risk Management 2011, 7:761-769
Published Date: 12 December 2011
Differential clinical profile of candesartan compared to other angiotensin receptor blockers
Cernes R, Mashavi M, Zimlichman R
Vascular Health and Risk Management 2011, 7:749-759
Published Date: 12 December 2011
Critical review of cancer risk associated with angiotensin receptor blocker therapy
Wuerzner G, Burnier M, Waeber B
Vascular Health and Risk Management 2011, 7:741-747
Published Date: 12 December 2011
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension
Palatini P, Casiglia E, Gąsowski J, Głuszek J, Jankowski P, Narkiewicz K, Saladini F, Stolarz-Skrzypek K, Tikhonoff V, Van Bortel L, Wojciechowska W, Kawecka-Jaszcz K
Vascular Health and Risk Management 2011, 7:725-739
Published Date: 7 December 2011
Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium
Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ
Vascular Health and Risk Management 2011, 7:719-724
Published Date: 2 December 2011
Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension
Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R
Vascular Health and Risk Management 2011, 7:709-717
Published Date: 30 November 2011
Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ
Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R
Vascular Health and Risk Management 2011, 7:701-708
Published Date: 24 November 2011
Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A
Vascular Health and Risk Management 2011, 7:693-699
Published Date: 22 November 2011
Effect of alcohol and tobacco use on vascular dementia: a matched case control study
Takahashi PY, Caldwell CR, Targonski PV
Vascular Health and Risk Management 2011, 7:685-691
Published Date: 15 November 2011
Telmisartan and cardioprotection
Akhrass PR, McFarlane SI
Vascular Health and Risk Management 2011, 7:677-683
Published Date: 15 November 2011
Vitamin D status and peripheral arterial disease: evidence so far
Chua GT, Chan YC, Cheng SW
Vascular Health and Risk Management 2011, 7:671-675
Published Date: 15 November 2011
Hemorrhagic infarction at 33 days after birth in a healthy full-term neonate
Kubo Y, Ogasawara K, Kurose A, Kashimura H, Koji T, Otawara Y, Kamei J, Akasaka M, Sasaki M, Ogawa A
Vascular Health and Risk Management 2011, 7:667-670
Published Date: 8 November 2011
Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
Mohammadi A, Sedani HH, Ghasemi-Rad M
Vascular Health and Risk Management 2011, 7:661-665
Published Date: 7 November 2011
Aneurysm of the tibial-saphenous fistula in hemodialysis patient: the results of surgical treatment
Günday M
Vascular Health and Risk Management 2011, 7:657-660
Published Date: 1 November 2011
Central aortic blood pressure, augmentation index, and reflected wave transit time: reproducibility and repeatability of data obtained by oscillometry
Ageenkova OA, Purygina MA
Vascular Health and Risk Management 2011, 7:649-656
Published Date: 1 November 2011
Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level
Bestehorn K, Jannowitz C, Horack M, Karmann B, Halle M, Völler H
Vascular Health and Risk Management 2011, 7:639-647
Published Date: 31 October 2011
Effects of smoking cessation on central blood pressure and arterial stiffness
Takami T, Saito Y
Vascular Health and Risk Management 2011, 7:633-638
Published Date: 20 October 2011
Prevalence of significant carotid artery stenosis in Iranian patients with peripheral arterial disease
Bavil AS, Ghabili K, Daneshmand SE, Nemati M, Bavil MS, Namdar H, Shaafi S
Vascular Health and Risk Management 2011, 7:629-632
Published Date: 11 October 2011
Retrograde rotational thrombectomy with the Rotarex® catheter system: treatment option for an acute thrombotic occlusion of a subclavian artery
Lichtenberg M, Kaeunicke M, Lukat M, Hailer B
Vascular Health and Risk Management 2011, 7:623-627
Published Date: 30 September 2011
Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk
Farsang C
Vascular Health and Risk Management 2011, 7:605-622
Published Date: 26 September 2011
Troponin elevation in conditions other than acute coronary syndromes
Tanindi A, Cemri M
Vascular Health and Risk Management 2011, 7:597-603
Published Date: 22 September 2011
Signs for early diagnosis of heart failure in primary health care
Devroey D, Van Casteren V
Vascular Health and Risk Management 2011, 7:591-596
Published Date: 14 September 2011
Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism
Kreidy R, Stephan E, Salameh P, Waked M
Vascular Health and Risk Management 2011, 7:585-589
Published Date: 15 September 2011
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials
Grossman E, Laudon M, Zisapel N
Vascular Health and Risk Management 2011, 7:577-584
Published Date: 15 September 2011
Superficial venous thrombosis: disease progression and evolving treatment approaches
Litzendorf ME, Satiani B
Vascular Health and Risk Management 2011, 7:569-575
Published Date: 31 August 2011
Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
Pham PA, Pham PT, Pham PC, Miller JM, Pham PM, Pham SV
Vascular Health and Risk Management 2011, 7:551-567
Published Date: 26 August 2011
Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production
Brown MD, Feairheller DL, Thakkar S, Veerabhadrappa P, Park JY
Vascular Health and Risk Management 2011, 7:541-550
Published Date: 26 August 2011
Extended-release ranolazine: critical evaluation of its use in stable angina
Truffa AAM, Newby LK, Melloni C
Vascular Health and Risk Management 2011, 7:535-539
Published Date: 25 August 2011
Lipid-lowering therapy: who can benefit
Lewis SJ
Vascular Health and Risk Management 2011, 7:525-534
Published Date: 24 August 2011
Arterial function of carotid and brachial arteries in postmenopausal vegetarians
Su TC, Torng PL, Jeng JS, Chen MF, Liau CS
Vascular Health and Risk Management 2011, 7:517-523
Published Date: 23 August 2011
Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital
Lotze U, Lemm H, Heyer A, Müller K
Vascular Health and Risk Management 2011, 7:509-515
Published Date: 19 August 2011
Renal artery stenosis in kidney transplants: assessment of the risk factors
Etemadi J, Rahbar K, Haghighi AN, Bagheri N, Falaknazi K, Ardalan MR, Ghabili K, Shoja MM
Vascular Health and Risk Management 2011, 7:503-507
Published Date: 10 August 2011
Comparing patients with spinal cord infarction and cerebral infarction: clinical characteristics, and short-term outcome
Naess H, Romi F
Vascular Health and Risk Management 2011, 7:497-502
Published Date: 4 August 2011
Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study
Radaideh G, Choueiry P, Ismail A, Eid E, Berrou JP, Sedefdjian A, Sévenier F, Pathak A
Vascular Health and Risk Management 2011, 7:491-495
Published Date: 1 August 2011
Incident prediabetes/diabetes and blood pressure in urban and rural communities in the Democratic Republic of Congo
Hightower JD, Hightower CM, Salazar Vázquez BY, Intaglietta M
Vascular Health and Risk Management 2011, 7:483-489
Published Date: 22 July 2011
Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects
Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G
Vascular Health and Risk Management 2011, 7:475-482
Published Date: 19 July 2011
Pre-eclampsia: pathophysiology, diagnosis, and management
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M
Vascular Health and Risk Management 2011, 7:467-474
Published Date: 19 July 2011
Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
Kwong LM
Vascular Health and Risk Management 2011, 7:461-466
Published Date: 18 July 2011
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
Hillegass WB, Brott BC, Dobbs JC, Papapietro SE, Misra VK, Zoghbi GJ
Vascular Health and Risk Management 2011, 7:445-459
Published Date: 18 July 2011
Depression in vascular pathologies: the neurologist's point of view
Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G
Vascular Health and Risk Management 2011, 7:433-443
Published Date: 12 July 2011
Racial differences in the responses to shear stress in human umbilical vein endothelial cells
Feairheller DL, Park J-Y, Rizzo V, Kim B, Brown MD
Vascular Health and Risk Management 2011, 7:425-431
Published Date: 11 July 2011
Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, Iran
Sadeghi-Bazargani H, Jafarzadeh H, Fallah M, Hekmat S, Bashiri J, Hosseingolizadeh GH, Soltanmohammadzadeh MS, Mortezazadeh A, Shaker A, Danehzan M, Zohouri A, Khosravi O, Nasimidoust R, Malekpour N, Kharazmi E, Babaei M, Nadirmohammadi M, Mashhadi-Abdoll H
Vascular Health and Risk Management 2011, 7:417-424
Published Date: 11 July 2011
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
Mason RP
Vascular Health and Risk Management 2011, 7:405-416
Published Date: 24 June 2011
Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
Kwan J, Htun WW, Huang Y, Ko W, Kwan T
Vascular Health and Risk Management 2011, 7:399-404
Published Date: 24 June 2011
Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials
Baumhäkel M, Böhm M
Vascular Health and Risk Management 2011, 7:391-397
Published Date: 23 June 2011
Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
Takami T, Saito Y
Vascular Health and Risk Management 2011, 7:383-390
Published Date: 17 June 2011
Stiffness of the large arteries in individuals with and without Down syndrome
Rodrigues AN, Coelho LC, Goncalves WLS, Gouvea SA, Vasconcellos MJR, Cunha RS, Abreu GR
Vascular Health and Risk Management 2011, 7:375-381
Published Date: 9 June 2011
Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out
Codreanu I, Robson MD, Rider OJ, Pegg TJ, Jung BA, Dasanu CA, Clarke K, Holloway CJ
Vascular Health and Risk Management 2011, 7:365-373
Published Date: 8 June 2011
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
Nappi J, Sieg A
Vascular Health and Risk Management 2011, 7:353-363
Published Date: 8 June 2011
Stentless aortic valve replacement: an update
Kobayashi J
Vascular Health and Risk Management 2011, 7:345-351
Published Date: 2 June 2011
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
Sezer ED, Sozmen EY, Nart D, Onat T
Vascular Health and Risk Management 2011, 7:333-343
Published Date: 1 June 2011
The occurrence of left ventricular hypertrophy in normotensive individuals in a community setting in North-East Trinidad
Bacchus R, Singh K, Ogeer I, Mungrue K
Vascular Health and Risk Management 2011, 7:327-332
Published Date: 6 July 2011
Early follow-up results of arteriovenous fistulae created for hemodialysis
Iyem H
Vascular Health and Risk Management 2011, 7:321-325
Published Date: 19 May 2011
Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
Ram C
Vascular Health and Risk Management 2011, 7:315-319
Published Date: 15 May 2011
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
Siragy HM
Vascular Health and Risk Management 2011, 7:297-313
Published Date: 19 May 2011
Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods
Barbosa J, Rodrigues A, Mota C, Barbosa M, Simoes e Silva AC
Vascular Health and Risk Management 2011, 7:287-295
Published Date: 10 May 2011
Cognitive evolution in hypertensive patients: a six-year follow-up
Vicario A, del Sueldo MA, Zilberman JM, Cerezo GH
Vascular Health and Risk Management 2011, 7:281-285
Published Date: 5 May 2011
Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta
Xue Y-L, Shi H-X, Murad F, Bian K
Vascular Health and Risk Management 2011, 7:273-280
Published Date: 28 April 2011
Relating patenting and peer-review publications: an extended perspective on the vascular health and risk management literature
Mucke HAM
Vascular Health and Risk Management 2011, 7:265-272
Published Date: 18 April 2011
Surgery in current therapy for infective endocarditis
Head SJ, Mokhles MM, Osnabrugge RLJ, Bogers AJJC, Kappetein AP
Vascular Health and Risk Management 2011, 7:255-263
Published Date: 19 April 2011
The causes, consequences, and treatment of left or right heart failure
Pazos-Lopez P, Peteiro-Vazquez J, Garcia-Campos A, Garcia-Bueno L, Abugattas-de-Torres JP, Castro-Beiras A
Vascular Health and Risk Management 2011, 7:237-254
Published Date: 4 April 2011
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program
Abraham I, MacDonald K, Hermans C, Aerts A, Lee C, Brié H, Vancayzeele S
Vascular Health and Risk Management 2011, 7:209-235
Published Date: 31 March 2011
Doppler study of cerebral arteries in hypercholesterolemia
Farhoudi M, Mehrvar K, Aslanabadi N, Ghabili K, Baghmishe NR, Ilkhchoei F
Vascular Health and Risk Management 2011, 7:203-207
Published Date: 31 March 2011
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation
Schmidt C, Kisselbach J, Schweizer PA, Katus HA, Thomas D
Vascular Health and Risk Management 2011, 7:193-202
Published Date: 31 March 2011
Olmesartan/amlodipine: a review of its use in the management of hypertension
Kreutz R
Vascular Health and Risk Management 2011, 7:183-192
Published Date: 29 March 2011
Olmesartan medoxomil for the treatment of hypertension in children and adolescents
Tocci G, Volpe M
Vascular Health and Risk Management 2011, 7:177-181
Published Date: 31 March 2011
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD
Vascular Health and Risk Management 2011, 7:169-176
Published Date: 28 March 2011
Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization
Grigorios Tsigkas, Panagiota Mylona, Periklis Davlouros, et al
Vascular Health and Risk Management 2011, 7:165-167
Published Date: 22 March 2011
Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications
Carlos V Serrano Jr, Karina Tiemi Setani, Erica Sakamoto, et al
Vascular Health and Risk Management 2011, 7:159-164
Published Date: 16 March 2011
Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience
Hikmat N Abdel-Razeq, Asem H Mansour, Yousef M Ismael
Vascular Health and Risk Management 2011, 7:153-158
Published Date: 15 March 2011
Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification
Carlos V Serrano Jr, Marcelo Oranges, Vitor Brunaldi, et al
Vascular Health and Risk Management 2011, 7:143-151
Published Date: 9 March 2011
Treatment options for hypertension in high-risk patients
Wei-Chuan Tsai
Vascular Health and Risk Management 2011, 7:137-141
Published Date: 9 March 2011
Coronary sinus intervention for the treatment of refractory angina pectoris
Yoav Paz, Amihay Shinfeld
Vascular Health and Risk Management 2011, 7:135-136
Published Date: 3 March 2011
Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease
Marco Matteo Ciccone, Asabella Artor Niccoli, Pietro Scicchitano, et al
Vascular Health and Risk Management 2011, 7:129-134
Published Date: 4 March 2011
The value of blood D-dimer test in the diagnosis of walk-in patients with venous thromboembolism
Shozo Yasuoka, Shunichiro Kubota
Vascular Health and Risk Management 2011, 7:125-127
Published Date: 1 March 2011
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
Zeenat Safdar
Vascular Health and Risk Management 2011, 7:119-124
Published Date: 2 March 2011
Novel drug-eluting stents in the treatment of de novo coronary lesions
Davide Capodanno, Fabio Dipasqua, Corrado Tamburino
Vascular Health and Risk Management 2011, 7:103-118
Published Date: 25 February 2011
Endothelial function in a cardiovascular risk population with borderline ankle–brachial index
Kari Syvänen, Päivi Korhonen, Auli Partanen, et al
Vascular Health and Risk Management 2011, 7:97-101
Published Date: 23 February 2011
Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)
Gerd Bönner, Bernhard Landers, Peter Bramlage
Vascular Health and Risk Management 2011, 7:85-95
Published Date: 17 February 2011
Decline of arterial cerebral infarction among young women: the Bergen Stroke Study
Halvor Naess, Annette Fromm, Ole Erik Iversen, et al
Vascular Health and Risk Management 2011, 7:81-84
Published Date: 15 February 2011
Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus
Samuel O Olusi, Sunila George
Vascular Health and Risk Management 2011, 7:75-80
Published Date: 15 February 2011
Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study
Ersen B Colkesen, Bart S Ferket, Jan GP Tijssen, et al
Vascular Health and Risk Management 2011, 7:67-74
Published Date: 9 February 2011
Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus
Asli Tanindi, Hilal Olgun, Ayse Tuncel, et al
Vascular Health and Risk Management 2011, 7:59-65
Published Date: 6 February 2011
Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Anja Schweizer, Sylvie Dejager, James E Foley, et al
Vascular Health and Risk Management 2011, 7:49-57
Published Date: 4 February 2011
Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer
Devi Charan Shetty, Puneet Ahuja, DK Taneja, et al
Vascular Health and Risk Management 2011, 7:41-47
Published Date: 27 January 2011
Congenital agenesis of internal carotid artery with ipsilateral Horner presenting as focal neurological symptoms
Wassim Farhat, Rechdi Ahdab, Hassan Hosseini
Vascular Health and Risk Management 2011, 7:37-40
Published Date: 26 January 2011
Hyperhomocysteinemia decreases bone blood flow
Neetu Tyagi, Thomas P Vacek, John T Fleming, et al
Vascular Health and Risk Management 2011, 7:31-35
Published Date: 25 January 2011
Antiplatelet combinations for prevention of atherothrombotic events
Mario Bollati, Fiorenzo Gaita, Matteo Anselmino
Vascular Health and Risk Management 2011, 7:23-30
Published Date: 12 January 2011
ACE up the sleeve – are vascular patients medically optimized
AP Coveney, GC O'Brien, GJ Fulton
Vascular Health and Risk Management 2011, 7:15-21
Published Date: 7 January 2011
Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits
Clodagh SM O’Gorman, Michael B O’Neill, Louise S Conwell
Vascular Health and Risk Management 2011, 7:1-14
Published Date: 20 December 2010